同年國際抗體驗證工作組 (IWGAV) 在Nature Methods期刊上在線發(fā)表題為「A Proposal for Validation of Antibodies」的文章,提出五點策略即:遺傳策略、正交策略、獨立抗體策略、表達標(biāo)記蛋白、免疫捕獲加上質(zhì)譜分析,以指導(dǎo)特定應(yīng)用中的抗體驗證。Uhlén博士認為,驗證抗體特異性是目前確??贵w持續(xù)可重復(fù)性最重要的步驟,確??贵w能特異性識別其預(yù)期靶標(biāo),并持續(xù)保持相似的性能,從而讓所有按照既定實驗方案操作的使用者最終都能獲得相同的結(jié)果。IWGAV提出的這些驗證策略是抗體特異性和重復(fù)性驗證不可或缺的起始步驟。
Madhusoodanan ( 2014年)和Rhodes & trickers ( 2008年)證實,在用于驗證抗體的所有方法中,敲除驗證的可接受性和可信度都很高。基因敲除 (Knockout, KO) 驗證基于KO樣品或細胞系的使用,KO樣品或細胞系是一種不表達目的蛋白的樣品或細胞系,因為負責(zé)編碼它的基因已經(jīng)被敲除或消除。在 KO 細胞系中測試特異性抗體時,特異性抗體不會產(chǎn)生信號,但在野生型 (wild type, WT) 細胞系測試特異性抗體時,特異性抗體會產(chǎn)生特異性目的蛋白信號。以這種方式,KO 驗證作為真正的陰性對照,以確認抗體對目的蛋白的特異性( bordeau等,2010年)。
Bioss高特異性KO驗證抗體有常見的腫瘤、信號轉(zhuǎn)導(dǎo)、細胞凋亡等相關(guān)抗體,解決實驗中的重現(xiàn)危機,不僅高保障產(chǎn)品質(zhì)量,還可以為科研人員在選購抗體時提供參考數(shù)據(jù),讓客戶能夠更快地找到穩(wěn)定可靠的抗體產(chǎn)品,節(jié)約科研工作者寶貴的實驗樣本和時間,加速科研成果產(chǎn)出。
[KO Validated]EGFR mAb [KO Validated]HSP90 beta mAb
[KO Validated]Phospho-Bad(Ser118)pAb [KO Validated]Vimentin pAb
[KO Validated]Lamin B1 pAb [KO Validated]N-Cadherin pAb
Bioss KO驗證抗體列表
產(chǎn)品編號
英文名稱
交叉反應(yīng)
產(chǎn)品應(yīng)用
bs-55138R
Anti-N-Cadherin
Human,Mouse,Rat
WB,ELISA
bs-55141R
Anti-NDRG1
Human,Mouse,Rat
WB,ELISA
bs-55160R
Anti-p21
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F
bs-55166R
Anti-PDCD4
Human,Mouse
WB,ELISA
bs-55164R
Anti-PARP
Human,Mouse,Rat
WB,ELISA
bs-55176R
Anti-PRKAR2A
Human,Mouse,Rat
WB,ELISA
bs-55182R
Anti-PTPN1
Human,Mouse,Rat
WB,ELISA
bs-55187R
Anti-RHOC
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F,IF
bs-55193R
Anti-SCD
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F,IF
bs-55199R
Anti-SIRT3
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F
bs-55203R
Anti-SMARCA4
Human
WB,ELISA
bs-55207R
Anti-SQSTM1/p62
Human,Mouse,Rat
WB,ELISA
bs-55209R
Anti-STK4
Human,Mouse,Rat
WB,ELISA
bs-55211R
Anti-TAGLN2
Human,Mouse
WB,ELISA,IF
bs-55069R
Anti-ERK2
Human,Mouse,Rat
WB,ELISA
bs-55093R
Anti-HDAC1
Human,Mouse,Rat
WB,ELISA,IP,IHC-P,IHC-F,IF
bs-55118R
Anti-Lamin B1
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F
bs-55024R
Anti-Beclin 1
Human,Mouse,Rat
WB,IHC-P,IHC-F,ICC,IF
bs-0756R
Anti-Vimentin
Human,Mouse
WB,ELISA,IHC-P,IHC-F,FCM,IF,ICC
bs-0608R
Anti-ICAM1/CD54
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F,FCM,IF,ICC
bs-0921R
Anti-SIRT1
Human,Mouse
WB,ELISA,IHC-P,IHC-F,FCM,IF
bs-2590R
Anti-NRSF
Human,Mouse
WB,ELISA,IP,IHC-P,IHC-F,IF
bs-1339R
Anti-CK18
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F,FCM,IF,ICC
bs-10100R
Anti-HSP90 alpha
Human,Mouse
WB,ELISA,IHC-P,IHC-F,IF,ICC
bs-5216R
Anti-Phospho-Bad (Ser118)
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F,FCM,IF,ICC
bs-20699R
Anti-Galectin 3
Human,Rat
WB,ELISA,FCM
bs-11262R
Anti-TMP21
Human,Mouse
WB,ELISA,IHC-P,IHC-F,IF,ICC
bs-8533R
Anti-Vimentin
Human,Mouse,Rabbit
WB,ELISA,IHC-P,IHC-F,FCM,IF,ICC
bsm-33293M
Anti-GSK-3 Beta
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F,IF,ICC
bsm-33136M
Anti-HSP90 beta
Human,Mouse,Rat
WB
bsm-33050M
Anti-EGFR
Human
WB,IHC-P,IHC-F,IF
bsm-33170M
Anti-Vimentin
Human
WB
bsm-33117M
Anti-NFKB p65
Human,Mouse,Rat
WB,ELISA,IHC-P,IHC-F,IF,ICC